Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-06 Purchase | 2023-12-07 5:23 pm | NKGen Biotech Inc. | NKGN | Song Paul Y. Chief Executive Officer | 151 | $3.3049 | $500 | 171,121 (Direct) | View |
| 2023-12-04 Purchase | 2023-12-05 3:51 pm | NKGen Biotech Inc. | NKGN | Song Paul Y. Chief Executive Officer | 268 | $3.172 | $850 | 170,969 (Direct) | View |
| 2023-12-01 Purchase | 2023-12-05 3:50 pm | NKGen Biotech Inc. | NKGN | Graf James A Graf Acquisition Partners IV LLC Interim CFO | 670 | $3.2425 | $2,173 | 2,437,437 (Indirect Direct) | View |
| 2023-11-27 Purchase | 2023-11-28 4:10 pm | NKGen Biotech Inc. | NKGN | Song Paul Y. Chief Executive Officer | 244 | $2.8754 | $701 | 170,701 (Direct) | View |
| 2023-11-20 Purchase | 2023-11-22 5:55 pm | NKGen Biotech Inc. | NKGN | Graf James A Graf Acquisition Partners IV LLC Interim CFO | 23 | $2.9259 | $67 | 2,436,767 (Indirect Direct) | View |
| 2023-11-21 Purchase | 2023-11-22 5:53 pm | NKGen Biotech Inc. | NKGN | Song Paul Y. Chief Executive Officer | 153 | $2.8172 | $430 | 170,458 (Direct) | View |
| 2021-05-28 Purchase | 2021-06-03 06:03 am | Graf Acquisition Corp. IV | GFOR | Graf James A Chief Executive Officer | 5,000 | $9.9 | $49,500 | 4,237,175 (Direct) | View |
| 2021-05-25 Purchase | 2021-05-27 4:57 pm | Graf Acquisition Corp. IV | GFOR | Graf James A Chief Executive Officer | 500 | $9.9192 | $4,960 | 4,254,300 (Direct) | View |
| 2021-05-25 Purchase | 2021-05-26 9:05 pm | Graf Acquisition Corp. IV | GFOR | Garcia Gus Co-President | 1,500 | $9.924 | $14,886 | 1,500 (Direct) | View |
| 2021-05-21 Purchase | 2021-05-25 7:45 pm | Graf Acquisition Corp. IV | GFOR | Graf James A Chief Executive Officer | 1,300 | $9.9412 | $12,924 | 8,506,300 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-20 Other | 2024-12-26 7:20 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 63,634 | $0 | 3,388,444 (Direct) | View |
| 2024-12-20 Disposition | 2024-12-26 7:20 pm | 2023-10-29 2028-09-29 | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 851,276 | $0 | 3,388,444 (Direct) | View |
| 2024-12-02 Other | 2024-12-23 4:01 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 290,603 | $0 | 11,790,441 (Direct) | View |
| 2024-12-02 Disposition | 2024-12-23 4:01 pm | 2023-10-29 2028-09-29 | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 3,151,094 | $0 | 11,790,441 (Direct) | View |
| 2024-12-06 Option Award | 2024-12-10 9:56 pm | N/A 2034-12-06 | NKGen Biotech Inc. | NKGN | Scott Kathleen D. Director | 800,000 | $0 | 800,000 (Direct) | View |
| 2024-12-06 Option Award | 2024-12-10 9:56 pm | N/A 2034-12-06 | NKGen Biotech Inc. | NKGN | Klowden Michael Director | 800,000 | $0 | 800,000 (Direct) | View |
| 2024-12-06 Option Award | 2024-12-10 9:56 pm | N/A 2034-12-06 | NKGen Biotech Inc. | NKGN | Song Paul Y. Chief Executive Officer | 2,000,000 | $0 | 2,000,000 (Direct) | View |
| 2024-12-06 Option Award | 2024-12-10 9:55 pm | N/A 2034-12-06 | NKGen Biotech Inc. | NKGN | Graf James A Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
Ownership | 2024-08-27 6:45 pm | N/A N/A | NKGen Biotech Inc. | NKGN | CFIC-2015 NV Family Investments LLC Cherng Andrew Jin-Chan CHERNG PEGGY 10% Owner | 0 | $0 | 8,291,666 (Indirect) | View |
| 2024-07-11 Option Award | 2024-07-18 5:53 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Gottardis Marco Director | 300,000 | $0 | 16,667 (Direct) | View |
Ownership | 2024-07-18 5:52 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Gottardis Marco Director | 0 | $0 | 300,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:20 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Scott Kathleen D. Director | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:19 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Kim Yong Man CSO and CIO | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:16 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Song Paul Y. Chief Executive Officer | 1,260,000 | $0 | 1,260,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:14 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Gagnon Pierre Chief Operating Officer | 360,000 | $0 | 360,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:11 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Klowden Michael Director | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-12-13 Gift | 2023-12-15 9:02 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Park Sangwoo NKMAX Co. Ltd. See Remarks 10% Owner | 2,500,000 | $0 | 10,517,990 (Indirect) | View |
Ownership | 2023-10-10 4:11 pm | N/A 2029-10-22 | NKGen Biotech Inc. | NKGN | Gagnon Pierre Chief Operating Officer | 0 | $0 | 161,834 (Direct) | View |
Ownership | 2023-10-10 4:10 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Kim Yong Man CSO and CIO | 0 | $0 | 161,834 (Direct) | View |
Ownership | 2023-10-10 4:06 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Song Paul Y. Chief Executive Officer | 0 | $0 | 647,339 (Direct) | View |
Ownership | 2023-10-10 4:04 pm | N/A N/A | NKGen Biotech Inc. | NKGN | Park Sangwoo NKMAX Co. Ltd. See Remarks 10% Owner | 0 | $0 | 15,753,457 (Indirect) | View |
| 2023-09-29 Option Award | 2023-10-04 06:10 am | 2023-10-29 2028-09-29 | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 5,244,673 | $1.5 | 14,176,581 (Direct) | View |
| 2023-09-29 Other | 2023-10-04 06:10 am | N/A N/A | NKGen Biotech Inc. | NKGN | Graf Acquisition Partners IV LLC Graf James A 10% Owner | 1,773,631 | $0 | 14,176,581 (Direct) | View |
| 2021-07-14 Other | 2021-07-14 4:54 pm | N/A N/A | Graf Acquisition Corp. IV | GFOR | Graf Acquisition Partners IV LLC Graf James A Chief Executive Officer 10% Owner | 20,000 | $0 | 4,230,375 (Direct) | View |
Ownership | 2021-07-14 4:53 pm | N/A N/A | Graf Acquisition Corp. IV | GFOR | LEBENTHAL ALEXANDRA Director | 0 | $0 | 20,000 (Direct) | View |
| 2021-06-02 Other | 2021-06-02 5:13 pm | N/A N/A | Graf Acquisition Corp. IV | GFOR | Graf Acquisition Partners IV LLC Graf James A Chief Executive Officer 10% Owner | 22,125 | $0 | 4,252,500 (Direct) | View |
Ownership | 2021-05-20 7:25 pm | N/A N/A | Graf Acquisition Corp. IV | GFOR | Cruz Anatolio B III Director | 0 | $0 | 20,000 (Direct) | View |